Prosensa secures $29.92 million in venture financing - MarketLine Financial Deals

Prosensa secures $29.92 million in venture financing

Prosensa secures $29.92 million in venture financing - MarketLine Financial Deals
Prosensa secures $29.92 million in venture financing
Published Jan 25, 2012
4 pages — Published Jan 25, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Prosensa B.V., a Netherlands-based biopharmaceutical company, has secured EUR23 million in new equity financing led by new investor New Enterprise Associates, Inc. (NEA).

  
Source:
Document ID
MA96545_120130
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Prosensa secures $29.92 million in venture financing" Jan 25, 2012. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Prosensa-secures-29-92-million-in-venture-financing-2052-76732>
  
APA:
MarketLine Financial Deals. (2012). Prosensa secures $29.92 million in venture financing Jan 25, 2012. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Prosensa-secures-29-92-million-in-venture-financing-2052-76732>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.